The diagnostic significance of plasma 1, 5-anhydroglucitol (AG) in screening for diabetes mellitus was studied in 2150 subjects undergoing complete medical check-ups [1626 subjects with normal glucose tolerance (NS), 393 patients with impaired glucose tolerance (IGT) and 131 diabetic patients (DM)]. The assays of fasting plasma glucose (FPG), hemoglobin A
1c (HbA
1c), plasma fructosamine (FRA) and AG were performed on samples taken from the subjects. The ratios of FPG to AG (FPG/AG), of HbA
1c to AG (HbA
1c/AG) and of FRA to AG (FRA/AG) were then calculated.
Receiver operating characteristic curves showed that AG and FPG/AG were superior to FPG, HbA
1c, FRA, HbA
1c/AG and FRA/AG as diagnostic tests for diabetes mellitus. An AG level lower than the cut-off value (15.5μg/m
l) was noted in 5.4% of NS, 15.5% of IGT, and 90.1% of DM. Furthermore, an FPG/AG level higher than the cut-off value (6.0mg/d
l/[μg/m
l]) was found in 5.7% of NS, 19.8% of IGT, and 93.9% of DM. According to the diagnostic sensitivity and specificity of the tests, both AG and FPG/AG measurements were superior to FPG, HbA
1c, FRA, HbA
1c/AG and FRA/AG determinations for diabetes screening.
From the above results, it can be concluded that AG or FPG/AG measurements in screening for diabetes mellitus are useful in diagnosing diabetic patients.
View full abstract